ArticleThe Yale journal of biology and medicine2021
2020 Evaluation of Portable Vision Screening Instruments.
Article in The Yale journal of biology and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Quantitative Assessment of Strabismus Using Cloud AI Computing: Validation Study.JMIR formative research · 2025Article
- Recommended practices for vision screening in pre-school-age children: A 2025 update.Optometry and vision science : official publication of the American Academy of Optometry · 2025Review
- Comparative Validation of MOPTIM MRT-200 Refraction Device with 2WIN and Retinomax.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Analysis of risk factors associated with the high incidence of amblyopia in preterm infants at the corrected gestational age of 12 months.BMC pediatrics · 2023Article
- Evaluation of the Blinq Vision Screener in the Detection of Amblyopia and Strabismus in Children.Translational vision science & technology · 2022Article
- Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- The UCI EyeMobile Preschool Vision Screening Program: Refractive Error and Amblyopia Results from the 2019-2020 School Year.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Portable hardware & software technologies for addressing ophthalmic health disparities: A systematic review.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Amblyopia is the most common cause of preventable visual impairment in children and occurs as a result of unilateral or bilateral impairment in best-corrected visual acuity. Early diagnosis and proper treatment are crucial to prevent poor visual outcomes in adulthood. Advances in technology have provided more objective diagnostic tools, which can now be used by a wide range of healthcare providers. Here, we highlight tools that have gained popularity in the past two decades and compare clinically relevant parameters to guide primary care providers seeking to incorporate instrumental vision screening in pediatric patient care.
Indexed as
Identifiers
33795987PMC7995935W3140174514What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.